NovioGendix's Acquisition

NovioGendix was acquired by MDxHealth on September 15, 2015.

NovioGendix is a privately-held molecular diagnostics company focused on the development of a non-invasive liquid biopsy test for prostate cancer.…

Articles about NovioGendix's Acquisition: